Therapeutic trials of multiple sclerosis and intrathecal IgG production.
In our clinical trial we have compared the effect of high doses of prednisone, ACTH alone or ACTH and cyclophosphamide on plasma and CSF albumin and IgG levels. We have found that the treatment with high doses of prednisone is more effective in the suppression of CNS IgG synthesis than ACTH, or cyclophosphamide. However the significance of this immunological phenomenon in the pathogenesis of MS is a very complex problem, since we have not observed any correlation between the depression of the intrathecal IgG synthesis and clinical results of MS treatment.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000418:Albumins / Q000134:cerebrospinal fluid; D002490:Central Nervous System / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000134:cerebrospinal fluid; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use*
D000418:Albumins; D007074:Immunoglobulin G; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D011241:Prednisone